Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

Author： Benedict Ágnes   Brown Ruth E  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.11, 2005-09, pp. : 1789-1801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Economics of Hormonal Therapies for Advanced Breast Cancer

By Simon Michael S.  

Drugs & Aging, Vol. 19, Iss. 6, 2002-01 ,pp. : 453-463

Adis International

Access to resources Recommend Favorite

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

By Hatoum Hind T   Crawford E David   Nielsen Sandy Kildegaard   Lin Swu-Jane   Marshall Dennis C  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 261-270

Informa Healthcare

Access to resources Recommend Favorite

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia

By Lindgren P.  

PharmacoEconomics, Vol. 20, Iss. 2, 2002-02 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness

By Karnon Jonathan  

PharmacoEconomics, Vol. 24, Iss. 3, 2006-01 ,pp. : 215-232

Adis International

Access to resources Recommend Favorite